Codexis (NasdaqGS:CDXS) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Codexis to reach your target.
Hmm, we can't give any reliable projection for Codexis's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.
None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
| CDXS Price (Codexis stock price per share) |
$1.44 | |
| PE Ratio versus Sector | 100% lower than other Basic Materials stocks | |
| PE Ratio versus Industry | 100% lower than other Chemicals stocks | |
| Cash Yield | -15.41% | |
| Free Cash Flow Jitter | 28% |
No open-market insider buys or sells are recorded in the six months to 2026-11-12.
The six months before that had 0 buys and 6 sales.
Open-market buys and sells reported by Codexis's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-12-01 | Opaleye Management Inc. | Sell | 245,000 | $1.67 |
| 2025-12-01 | Opaleye Management Inc. | Sell | 8,533 | $1.67 |
| 2025-11-28 | Opaleye Management Inc. | Sell | 2,490 | $1.75 |
| 2025-11-28 | Opaleye Management Inc. | Sell | 105,000 | $1.75 |
| 2025-11-26 | Opaleye Management Inc. | Sell | 148,318 | $1.74 |
| 2025-11-26 | Opaleye Management Inc. | Sell | 5,000 | $1.74 |
| 2025-11-12 | Opaleye Management Inc. | Sell | 27,459 | $1.94 |
| 2025-11-12 | Opaleye Management Inc. | Sell | 165,000 | $1.96 |
| 2025-11-12 | Opaleye Management Inc. | Sell | 890,000 | $1.94 |
| 2025-11-11 | Opaleye Management Inc. | Sell | 535,000 | $1.80 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 3,724,621 shares shorted. With 82,348,335 shares available for purchase and an average trading volume over the past 10 trading days of 817,530, it would take at least 4.6 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
Each year names the SEC filer that reported it, so a change of filer shows up here.
| Fiscal year | SEC filer (CIK) | Free cash flow (USD millions) |
|---|---|---|
| 2009 | 1200375 | -19.5 |
| 2010 | 1200375 | -25.2 |
| 2011 | 1200375 | -10.0 |
| 2012 | 1200375 | -19.7 |
| 2013 | 1200375 | -29.5 |
| 2014 | 1200375 | -4.1 |
| 2015 | 1200375 | -3.7 |
| 2016 | 1200375 | -3.2 |
| 2017 | 1200375 | -9.7 |
| 2018 | 1200375 | -15.3 |
| 2019 | 1200375 | -14.5 |
| 2020 | 1200375 | -18.9 |
| 2021 | 1200375 | -19.3 |
| 2022 | 1200375 | 4.8 |
| 2023 | 1200375 | -59.4 |
| 2024 | 1200375 | -56.3 |
| 2025 | 1200375 | -26.4 |
Download the yearly data as CSV.
Of the 17 fiscal years we can see for Codexis under its current filer, 1 show positive free cash flow.
Year-to-year variability in free cash flow is uneven, measured at 28%.
We do not estimate a fair value for Codexis while its free cash flow growth is not positive, so there is no value comparison here.
Dividends are not in our data for Codexis.
Before you act on any of this, read what a margin of safety means and check the company's own filings.
Its trailing P/E ratio is 100% below the average for stocks in the Basic Materials sector.
Its trailing P/E ratio is 100% below the average for stocks in the Chemicals industry.
A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.
Every fiscal year on this page is reported by one SEC filer, CIK 1200375.
Each figure on this page comes from that filer.
Advertisement supports free stock analysis content.
Does Codexis have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to CDXS: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
Why Does the Media Cover the Stock Market So Poorly?
Is There a Secret Formula to Pick Good Stocks?
DCA vs Lump Sum: 155 Years of S&P 500 Historical Data
Always Choose Employer Matching 401k Contributions
What is Self-Directed Investing?